You are here Home Resources and guidance Sponsors Amivas Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Designation or determination (3) Prescription medicine evaluation (1) Date 2024 (2) 2023 (2) Search Sponsor content4 result(s) found, displaying 1 to 4 Artesunate Amivas Amivas Australia Pty Ltd Aug-2024 Prescription medicine evaluation Active ingredient: Artesunate. Notice for Artesunate (Amivas Australia Pty Ltd) 25 March 2024 Designation or determination Orphan drug Notice for Artesunate (Amivas Australia Pty Ltd) 12 October 2023 Designation or determination Priority review Notice for Artesunate (Amivas Australia Pty Ltd) 10 October 2023 Designation or determination Orphan drug
Artesunate Amivas Amivas Australia Pty Ltd Aug-2024 Prescription medicine evaluation Active ingredient: Artesunate.
Notice for Artesunate (Amivas Australia Pty Ltd) 25 March 2024 Designation or determination Orphan drug
Notice for Artesunate (Amivas Australia Pty Ltd) 12 October 2023 Designation or determination Priority review
Notice for Artesunate (Amivas Australia Pty Ltd) 10 October 2023 Designation or determination Orphan drug